Zymeworks Inc. (NASDAQ:ZYME) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET
Company Participants
Shrinal Inamdar – Senior Director, Investor Relations
Ken Galbraith – Chair & CEO
Paul Moore – Chief Scientific Officer
Leone Patterson – Executive Vice President, Chief Business and Financial Officer
Conference Call Participants
Charles Zhu – LifeSci Capital
Brian Cheng – JPM
Stephen Willey – Stifel
Jonathan Miller – Evercore ISI
Amanda Acosta-Ruiz – Leerink Partners
Yigal Nochomovitz – Citigroup
Eva Fortea-Verdejo – Wells Fargo
Robert Burns – H.C. Wainwright
Operator
Thank you for standing by. This is the conference operator. Welcome to Zymeworks First Quarter 2025 Results Conference Call and Webcast. As a reminder, all participants are in listen-only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. [Operator Instructions]
I would now like to turn the conference over to Shrinal Inamdar, Senior Director of Investor Relations. Shrinal, please go ahead.
Shrinal Inamdar
Thank you operator and good afternoon everyone. Thank you for joining our first quarter 2025 results conference call. Before we begin, I would like to remind you that we’ll be making a number of forward-looking statements during this call, including, without limitation, those forward-looking statements identified in our slides and the accompanying oral commentary. Forward-looking statements are based upon our current expectations and various assumptions, and are subject to the usual risks and uncertainties associated with companies in our industry and at our stage of development. For a discussion of these risks and uncertainties, we refer you to our latest SEC filings as found on our website and as filed with the SEC.
In a moment, I will be handing over to Leone Patterson, our Executive Vice President and Chief Business and Financial Officer. He will be discussing recent business updates along with financial
Read the full article here
